WALDENCAST PLC (WALD)
Obagi Medical Announces FDA Approval of Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel
Obagi Medical Announces FDA Approval of Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel
Wells Fargo Named as ICON Preferred Mortgage Lender to Support 3D‑Printed Homes
Wiley and IQVIA Release Cross-Sector Report on AI’s Promise and Pressure Points Across Healthcare Value Chain
XBiotech Launches Phase II Clinical Trial Evaluating Vilamakitug for the Treatment of Active Axial Spondyloarthritis
enGene Reports Second Quarter 2026 Financial Results and Provides Business Update
XBiotech lance un essai clinique de phase II visant à évaluer le vilamakitug dans le traitement de la spondylarthrite axiale active
MAAS Subsidiary Huazhi Future Establishes Green Energy Infrastructure Research Team, Designates 800VDC as a Core Technology Focus
Principal Asset Management® Launches Fixed Income ETF Suite
Markel Canada Strengthens Contractors, Trades and Construction Services (CTCS) Sector Leadership With Key Appointments
Preclinical Data for OPKO Biologics OPK8801001 in Acromegaly Presented at ENDO 2026